Upstream Bio, Inc. Financial Flexibility Index
Upstream Bio, Inc. financial flexibility index. Upstream Bio, Inc. (UPB) has a Financial Flexibility Index of -3.49x as of June 2026. Free cash flow of $-35.62 Million (operating CF $-35.62 Million minus capex $0.00) represents -3% of total liabilities ($10.21 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Upstream Bio, Inc. (2022–2025)
Financial flexibility index of Upstream Bio, Inc. from 2022 to 2025. Historical Financial Flexibility Index trend for Upstream Bio, Inc. across 4 annual periods. Explore Upstream Bio, Inc. (UPB) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Upstream Bio, Inc. Financial Flexibility Index by Year (2022–2025)
Upstream Bio, Inc. financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for Upstream Bio, Inc.. For the full cash flow conversion analysis, see Upstream Bio, Inc. cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -9.51x | $-133.11 Million | $-133.28 Million | $14.00 Million | ▼ -92.3% |
| 2024 | -4.94x | $-58.66 Million | $-59.17 Million | $11.87 Million | ▼ -3044.3% |
| 2023 | -0.16x | $-37.78 Million | $-37.93 Million | $240.32 Million | ▼ -3.5% |
| 2022 | -0.15x | $-18.94 Million | $-19.02 Million | $124.63 Million | — |